{"id":18429,"date":"2020-11-10T19:44:17","date_gmt":"2020-11-10T18:44:17","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=18429"},"modified":"2020-11-10T20:54:15","modified_gmt":"2020-11-10T19:54:15","slug":"enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/","title":{"rendered":"ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">ENPICOM B.V., an innovative bioinformatics software engineering company delivering ground-breaking products and customized solutions to decode the immune system and improve human health, announced the company has entered into a service agreement with Neogene Therapeutics to grant the company access to ENPICOM\u2019s cloud-based <a href=\"https:\/\/enpicom.com\/igx-platform\/\">IGX Platform<\/a> to manage, organize, and analyze T cell sequencing data. ENPICOM has additionally developed a number of customizations making sure that the platform\u2019s functionality fits Neogene\u2019s specific data handling workflow to help Neogene\u2019s research team leverage the full potential of their immune repertoire data.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201c<em>We are extremely proud to add Neogene Therapeutics to our IGX Platform customer base. Their recent $110 million Series A shows how important this new type of immunotherapy has become in the last few years<\/em>,\u201d stated Jos Lunenberg, CEO of ENPICOM.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dedicated to developing personalized neoantigen T cell receptor (TCR) therapies for cancer, Neogene Therapeutics extensively studies immune repertoires of cancer patients by high-throughput T cell sequencing in order to identify T cell receptor genes with therapeutic value. Personalized neo-antigen TCR therapy is a novel approach to cancer treatment, where a patient\u2019s T cells are genetically engineered with neoantigen specific TCR genes to enable them to identify and destroy tumor cells.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Carsten Linnemann, CEO of Neogene Therapeutics, added: \u201c<em>ENPICOM and the Neogene team have been collaborating for several years on various projects. ENPICOM has always been a thoughtful and highly reliable partner. It is a pleasure to utilize their innovative and unique IGX Platform<\/em>.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Since immune repertoire sequencing implies the generation of large amounts of data, there is a need for specific expertise to efficiently manage and fully exploit the potential of the data collected. ENPICOM\u2019s IGX Platform provides Neogene with an efficient solution to manage and annotate T cell sequencing data.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The IGX Platform comes with powerful data management features and an intuitive user interface out of the box. Its modular, flexible structure allows for further enhancements and customizations. The custom robust workflow of the IGX Platform uniquely positions it to support high-throughput studies required to power Neogene\u2019s research in personalized T cell therapies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Source: Enpicom (<a href=\"https:\/\/enpicom.com\/news\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/\">Press release<\/a>)<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ENPICOM B.V., an innovative bioinformatics software engineering company delivering ground-breaking products and customized solutions to decode the immune system and improve human health, announced the company has entered into a service agreement with Neogene Therapeutics to grant the company access to ENPICOM\u2019s cloud-based IGX Platform to manage, organize, and analyze T cell sequencing data. ENPICOM [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[43],"tags":[],"class_list":["post-18429","post","type-post","status-publish","format-standard","hentry","category-innovatieklimaat"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution - hollandbio\" \/>\n<meta property=\"og:description\" content=\"ENPICOM B.V., an innovative bioinformatics software engineering company delivering ground-breaking products and customized solutions to decode the immune system and improve human health, announced the company has entered into a service agreement with Neogene Therapeutics to grant the company access to ENPICOM\u2019s cloud-based IGX Platform to manage, organize, and analyze T cell sequencing data. ENPICOM [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-10T18:44:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-10T19:54:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"HollandBIO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"HollandBIO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\\\/\"},\"author\":{\"name\":\"HollandBIO\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\"},\"headline\":\"ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution\",\"datePublished\":\"2020-11-10T18:44:17+00:00\",\"dateModified\":\"2020-11-10T19:54:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\\\/\"},\"wordCount\":370,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"Innovatieklimaat\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\\\/\",\"name\":\"ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2020-11-10T18:44:17+00:00\",\"dateModified\":\"2020-11-10T19:54:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\",\"name\":\"HollandBIO\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/","og_locale":"en_US","og_type":"article","og_title":"ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution - hollandbio","og_description":"ENPICOM B.V., an innovative bioinformatics software engineering company delivering ground-breaking products and customized solutions to decode the immune system and improve human health, announced the company has entered into a service agreement with Neogene Therapeutics to grant the company access to ENPICOM\u2019s cloud-based IGX Platform to manage, organize, and analyze T cell sequencing data. ENPICOM [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/","og_site_name":"hollandbio","article_published_time":"2020-11-10T18:44:17+00:00","article_modified_time":"2020-11-10T19:54:15+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"HollandBIO","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"HollandBIO","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/"},"author":{"name":"HollandBIO","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea"},"headline":"ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution","datePublished":"2020-11-10T18:44:17+00:00","dateModified":"2020-11-10T19:54:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/"},"wordCount":370,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["Innovatieklimaat"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/","name":"ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2020-11-10T18:44:17+00:00","dateModified":"2020-11-10T19:54:15+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/enpicom-services-neogene-therapeutics-with-its-t-cell-repertoire-sequencing-data-handling-and-analysis-solution\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"ENPICOM services Neogene Therapeutics with its T cell repertoire sequencing data handling and analysis solution"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea","name":"HollandBIO"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/18429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=18429"}],"version-history":[{"count":0,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/18429\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=18429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=18429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=18429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}